Startups

Good Culture Announces Majority Investment From L Catterton

By Amit Chowdhry ● Jan 11, 2026

Good Culture announced L Catterton has entered into a definitive agreement to make a majority investment in the Austin, Texas-based clean-label cultured dairy brand, positioning the company for expanded production capacity, broader distribution, and faster product innovation as demand for high-protein, clean-label foods continues to climb. Financial terms were not disclosed.

Barclays Backs Ubyx To Expand Connectivity For Tokenized Deposits And Stablecoins

By Amit Chowdhry ● Jan 11, 2026

Barclays has made a strategic investment in Ubyx, a U.S.-based clearing system designed to support new forms of digital money, including tokenized deposits and regulated stablecoins.

Torq: $140 Million Series D At $1.2 Billion Valuation Raised For Agentic AI-Focused Security Operations Platform

By Amit Chowdhry ● Jan 11, 2026

Torq, an agentic AI-focused security operations company, said it has raised $140 million in a Series D financing at a $1.2 billion valuation, bringing its total funding to $332 million. The round was led by Merlin Ventures with participation from existing investors Evolution Equity Partners, Notable Capital, Bessemer Venture Partners, Insight Ventures Partners and Greenfield Partners.

Andreessen Horowitz Raises Over $15 Billion Across New Funds

By Amit Chowdhry ● Jan 11, 2026

Andreessen Horowitz announced it has raised more than $15 billion in new capital, with co-founder Ben Horowitz framing the fundraise as part of the firm’s mission to help the United States maintain technological leadership in an increasingly competitive global environment.

Equitable Earth: €12.6 Million Raised To Advance Certification Of Nature-Based Climate Solutions

By Amit Chowdhry ● Jan 11, 2026

Equitable Earth has raised €12.6 million to expand its certification programme for nature-based carbon projects and invest further in data, technology and methodologies aimed at increasing trust and scalability in the voluntary carbon market.

Medipost Closes In $140 Million Funding To Back Planned U.S. Phase III Trial

By Amit Chowdhry ● Jan 11, 2026

MEDIPOST, a Cambridge, Massachusetts-based biotechnology company developing allogeneic, umbilical cord blood-derived stem cell therapies, said its parent company, MEDIPOST Co., Ltd., has closed $140 million in funding to accelerate late-stage clinical development and expand manufacturing and operational infrastructure.

AirNexis Therapeutics Launches With $200 Million Series A To Advance Phase 2 Dual PDE3/4 Inhibitor AN01 For COPD

By Amit Chowdhry ● Jan 11, 2026

AirNexis Therapeutics has launched as a clinical-stage biotechnology company focused on pulmonary diseases, closing a $200 million Series A financing and securing an in-license to a Phase 2 dual PDE3/4 inhibitor for chronic obstructive pulmonary disease (COPD) from Haisco Pharmaceutical Group.

FineHeart: €83 Million Secured To Develop Implantable Solutions For Cardiology

By Amit Chowdhry ● Jan 11, 2026

FineHeart, a clinical-stage medical technology company developing implantable solutions for cardiology, has secured a total of €83 million in financing that blends private capital with non-dilutive European public funding to advance its FlowMaker device and accelerate the company’s path toward industrialization and clinical development.

MagicCube: $10 Million Raised To Expand Beyond Tap-to-Phone

By Amit Chowdhry ● Jan 11, 2026

MagicCube, a provider of software-based security for payments and device integrity, said it has raised $10 million in new committed funding as it expands beyond tap-to-phone into biometrics, identity verification, and AI-driven device security.

Orca Bio: $250 Million Funding Raised For Orca-T Launch Readiness Ahead Of April PDUFA Date

By Amit Chowdhry ● Jan 11, 2026

Orca Bio announced it has raised $250 million in new equity financing and expanded access to debt capital as the late-stage biotech prepares for a potential U.S. commercialization of its lead cell therapy candidate, Orca-T, with an FDA action date set for April 6, 2026.